Decreased full-year guidance, margin pressure, and high valuations overshadow a strong immunology growth rate. How did earnings impact AbbVie’s outlook?
Concerns over profit margins, excessive valuations, and a dismal return on invested capital overshadowed excellent earnings. Will earnings spark a correction in AMD?